[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 168,632
  • Shares Outstanding, K 27,331
  • Annual Sales, $ 61,860 K
  • Annual Income, $ -11,430 K
  • EBIT $ -2 M
  • EBITDA $ 3 M
  • 60-Month Beta 1.03
  • Price/Sales 2.72
  • Price/Cash Flow N/A
  • Price/Book 5.45

Options Overview Details

View History
  • Implied Volatility 274.45% (+4.08%)
  • Historical Volatility 68.24%
  • IV Percentile 34%
  • IV Rank 30.70%
  • IV High 643.12% on 03/13/26
  • IV Low 111.12% on 03/27/26
  • Expected Move (DTE 28) 1.79 (28.74%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 114
  • Volume Avg (30-Day) 139
  • Put/Call OI Ratio 3.25
  • Today's Open Interest 1,884
  • Open Int (30-Day) 1,326
  • Expected Range 4.43 to 8.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.01
  • Number of Estimates 2
  • High Estimate $0.06
  • Low Estimate $-0.07
  • Prior Year $-0.16
  • Growth Rate Est. (year over year) +93.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.83 +28.57%
on 05/12/26
6.71 -7.45%
on 05/14/26
+1.29 (+26.22%)
since 04/21/26
3-Month
4.31 +44.08%
on 03/30/26
9.06 -31.46%
on 02/25/26
-2.29 (-26.94%)
since 02/20/26
52-Week
4.31 +44.08%
on 03/30/26
9.56 -35.01%
on 01/23/26
-0.57 (-8.41%)
since 05/21/25

Most Recent Stories

More News
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference

SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company...

FBIO : 2.78 (+4.91%)
DERM : 6.21 (+0.65%)
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million  Emrosi ® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash...

FBIO : 2.78 (+4.91%)
DERM : 6.21 (+0.65%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM). Such investors are...

DERM : 6.21 (+0.65%)
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026

SCOTTSDALE, Ariz., May 06, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused...

FBIO : 2.78 (+4.91%)
DERM : 6.21 (+0.65%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

NEW YORK , April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM).  Such investors...

DERM : 6.21 (+0.65%)
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™

SCOTTSDALE, Ariz., April 21, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical...

FBIO : 2.78 (+4.91%)
DERM : 6.21 (+0.65%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM).  Such investors...

DERM : 6.21 (+0.65%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

NEW YORK , April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM).  Such investors...

DERM : 6.21 (+0.65%)
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi ™  generated net revenues of $14.7 million during the full-year period after its launch in early April 2025...

FBIO : 2.78 (+4.91%)
DERM : 6.21 (+0.65%)
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

SCOTTSDALE, Ariz., March 18, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused...

FBIO : 2.78 (+4.91%)
DERM : 6.21 (+0.65%)

Business Summary

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

See More

Key Turning Points

3rd Resistance Point 6.62
2nd Resistance Point 6.48
1st Resistance Point 6.34
Last Price 6.21
1st Support Level 6.07
2nd Support Level 5.93
3rd Support Level 5.79

See More

52-Week High 9.56
Fibonacci 61.8% 7.55
Fibonacci 50% 6.93
Fibonacci 38.2% 6.31
Last Price 6.21
52-Week Low 4.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.